Food and Drug Administration (FDA) for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition
However, use these sparingly, as excessive use can impair thyroid function
Collection: Creams & Moisturizers Our Featured Moisturizer Meet the GHK-Cu Cream Skin SurgeMD's standout moisturizer formulated for loose, wrinkly, crepey, or sagging skin
The most frequently reported risks include injection-site pain, redness, or swelling
Supports research into skin rejuvenation and collagen production
It is always advisable that B12 injections should be administered by a medical expert to avoid such risks